Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × olaparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 19 Breast Neoplasms 10 Prostatic Neoplasms 9 Triple Negative Breast Neoplasms 7 Fallopian Tube Neoplasms 7 Neoplasm Metastasis 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Stomach Neoplasms 3 Small Cell Lung Carcinoma 3 Sarcoma 3 Neoplasms 3 Metastatic Castration-resistant Prostate Cancer 3 Fanconi Anemia, Complementation Group D1 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Pancreatic Neoplasms 2 Endometrial Neoplasms 2 Castration-Resistant Prostate Carcinoma 2 Carcinoma 2 Wilms Tumor 1 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Prostate 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡